Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration

Human ceIII ine derived from uterine cervix
cancer. Squamous ceII carcinoma .
APPIication consideration Struktur
CAS-Nr.
Englisch Name:
Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration
Synonyma:
J HUS-nk1;Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration
CBNumber:
CB621462496
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration Eigenschaften

Sicherheit

Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration Chemische Eigenschaften,Einsatz,Produktion Methoden

Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangdong Fanpu Biotechnology Co., Ltd. 19513720913
2708713838@qq.com China 4720 58

  • Human ceIII ine derived from uterine cervix cancer. Squamous ceII carcinoma . APPIication consideration
  • J HUS-nk1
Copyright 2019 © ChemicalBook. All rights reserved